A new era is dawning in diagnosing sexually transmitted infections in men

December 03, 2020

According to the World Health Organization, the global prevalence estimates of sexually transmitted infections for men in 2016 were 2.7% for chlamydia, 0.7% for gonorrhoea and 0.6% for trichomoniasis. In men, these and other sexually transmitted infections may lead to urethritis, inflammation of the urethra.

There are several methods for detecting these infections. In recent years, new technologies have emerged in the field of urinalysis methodology, offering quick and standardised opportunities in everyday clinical practice. One of the authors of the study, teaching physician at the Men's Clinic of Tartu University Hospital and doctoral student at the University of Tartu Faculty of Medicine Stanislav Tjagur said that one of such innovative diagnosing methods is flow cytometry: "Compared with other methods, this technique is simple to perform, automated, provides results rapidly, and is not invasive."

However, there is only limited information about how to use flow cytometry in diagnosing male urethritis. Therefore, medical researchers of the University of Tartu and andrologists of Tartu University Hospital conducted a study to evaluate the performance of flow cytometry on first-voided urine in males with infectious urethritis. "We aimed to find the optimal cut-off levels for a faster and more precise diagnosing of sexually transmitted infections associated with urethritis to improve the cost-effectiveness of the management of infectious urethritis in men in a busy outpatient clinic," described Tjagur.

Patients who had come to the Men's Clinic of Tartu University Hospital either after a case of high-risk sexual behaviour, for fertility check, or for prophylactic health control were involved in the study. Cases included 306 patients aged 18 to 50 years with chlamydia, gonorrhoea, Mycoplasma genitalium infection and/or trichomoniasis. The control group consisted of 192 patients of the same age group without urogenital complaints and negative for the listed infections.

The study indicated that among men who consulted with an andrologist, the most prevalent sexually transmitted infection was chlamydia (64.1%), followed by Mycoplasma genitalium infection (20.9%), gonorrhoea (7.8%) and trichomoniasis (1.6%). The total proportion of different combined infections was 5.6%. "The results measured by flow cytometry showed that gonorrhoea caused the highest inflammatory reaction and the highest bacterial count in first-voided urine," described Tjagur, who considers this finding one of the greatest values of the study, in addition to providing a good overview of the prevalence of sexually transmitted infections and the efficiency of diagnostics.

Tjagur concluded that flow cytometry can be considered a rapid and objective screening method in case of suspected male infectious urethritis, although further studies are needed to confirm the initial findings.
Authors of the article "Profile of sexually transmitted infections causing urethritis and a related inflammatory reaction in urine among heterosexual males: a flow-cytometry study" published in PLOS ONE are Stanislav Tjagur (teaching physician at the Men's Clinic of Tartu University Hospital and doctoral student at the University of Tartu Faculty of Medicine), Reet Mändar (Professor of Medical Microbial Ecology at the University of Tartu) and Margus Punab (Director of Men's Clinic of Tartu University Hospital, Professor in Andrology at the University of Tartu).

Estonian Research Council

Related Chlamydia Articles from Brightsurf:

Chlamydia: Greedy for glutamine
If chlamydiae want to multiply in a human cell, the first thing they need is a lot of glutamine.

Chlamydia build their own entrance into human cells
Chlamydia, a type of pathogenic bacteria, need to penetrate human cells in order to multiply.

Targeted gene modification in animal pathogenic chlamydia
Researchers at Umeå University (Sweden), in collaboration with researchers at the University of Maryland and Duke University (USA), now for the first time successfully performed targeted gene mutation in the zoonotic pathogen Chlamydia caviae.

How Chlamydia gain access to human cells
Infection biologists at Heinrich Heine University Düsseldorf (HHU) and the University of Freiburg have found out how the LIPP protein discovered in Düsseldorf helps Chlamydia to infect human cells.

Researchers discover how chlamydia takes up new DNA from host
A recent paper by a team of molecular biologists headquartered at the University of Kansas pinpointed a gene that allows chlamydia to take up DNA from its host environment.

Chlamydia in testicular tissue linked to male infertility
The potential impact of undiagnosed sexually transmitted chlamydia infection on men's fertility has been highlighted in a study led by scientists at Queensland University of Technology (QUT), which for the first time found chlamydia in the testicular tissue biopsies of infertile men whose infertility had no identified cause.

New rapid DNA test to diagnose chlamydia infection in koalas
A new DNA test to detect chlamydia infection in koalas which gives on-the-spot results within 30 minutes has been developed in a collaboration between researchers in Brisbane, Australia.

Researchers identify how vaginal microbiome can elicit resistance to chlamydia
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries.

The Lancet Infectious Diseases: First ever phase 1 trial of genital chlamydia vaccine finds it is safe and provokes immune response
The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response, according to a study published in The Lancet Infectious Diseases journal.

Last chlamydia-free koala population may safeguard future of species
The last, large, isolated, healthy chlamydia-free population of koalas in Australia may have been identified on Kangaroo Island, said Morris Animal Foundation-funded researchers at the University of Adelaide.

Read More: Chlamydia News and Chlamydia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.